patient advocacy


Alarm bell rung over EU’s unified HTA plan

The EU’s joint clinical assessment (JCA) initiative has been set up to accelerate patient access to new therapies, but could end up restricting the use of new technologies

Live from Reuters Pharma USA 2023

Reuters Pharma USA – Kevin Hagan

Working in the pharma industry, it’s important to be aware of the impact of policies on all stakeholders, from industry colleagues, to payers and providers, and to patients – including low-